June 26, 2018

Salk researchers win five competitive grants for cancer research

Padres Pedal the Cause funds 11 new collaborative cancer research projects

索尔克新闻


Salk researchers win five competitive grants for cancer research

拉霍亚—索尔克研究所的科学家 罗纳德·埃文斯, 戴安娜·哈格里夫斯, 托尼·亨特, Graham McVicker杰弗里·沃尔 are among the first wave of researchers to receive funding from Padres Pedal the Cause, one of one of the largest stand-alone cancer fundraising events in San Diego. The nonprofit raised $2.4 million for cancer research in November 2017, thanks to the efforts of more than 3,000 bicycle riders, sponsors, volunteers and donors.

Padres Pedal the Cause presented a check for $2,401,523.00 to representatives from Moores Cancer Center at UC San Diego Health, Sanford Burnham Prebys Medical Discovery Institute, the Salk Institute for Biological Studies and Rady Children’s Hospital–San Diego.

From left to right: Bill Koman, Padres Pedal Founder; Geoffrey M. Wahl, Ph.D. – Salk Institute for Biological Studies; Anne Marchand, Executive Director – Padres Pedal; Christopher J. Kane, MD – Moores Cancer Center at UC San Diego Health; Garth Powis, D. Phil. – Sanford Burnham Prebys Medical Discovery Institute; Donald Kearns, M.D., M.M.M., President & CEO – Rady Children’s Hospital–San Diego

点击此处 用于高分辨率图像

Credit: Padres Pedal the Cause

Pedal the Cause awards millions of dollars each year via its Discovery Grants program to cross-institutional teams of physicians and scientists from San Diego’s best cancer institutions, including the Salk Institute for Biological Studies, Moores Cancer Center at UC San Diego Health, Sanford Burnham Prebys Medical Discovery Institute and Rady Children’s Hospital.

“The Padres Pedal the Cause Discovery Grants are opening the door to critically needed research,” say Professors Geoffrey Wahl of Salk and Frank Furnari of UC San Diego, who are leading a 2018 Discovery Grant together. “This funding has allowed us to build a highly collaborative research team to tackle glioblastoma, a particularly aggressive brain cancer.”

According to Pedal the Cause, the Discovery Grant funding process is highly selective and proposals are screened via a rigorous vetting process. Funding is awarded to best-in-class project submissions to green-light project exploration with the hope that initial findings may lead to additional funding from national sources and, ultimately, a cure.

Salk scientists are co–principal investigators on Projects 3, 7, 8, 9 and 10 of the 2018 Discovery Grants listed below:

Project 1: “Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot”
Jack Bui, Moores Cancer Center
Peter Adams, Sanford Burnham Prebys Medical Discovery Institute

Project 2: “Understanding and Targeting NRF2 in Pancreatic Cancer”
Michael Karin, Moores Cancer Center
Andrew Lowy, Moores Cancer Center
Jorge Moscat, Sanford Burnham Prebys Medical Discovery Institute

Project 3: “Targeting a Therapeutic Vulnerability in PTEN-Deficient Brain Tumors”
Frank Furnari, Moores Cancer Center
杰弗里·沃尔, Salk Institute for Biological Studies

Project 4: “Natural Killer Cells for Treatment of Medulloblastoma”
Dan S. Kaufman, Moores Cancer Center
Robert J. Wechsler-Reya, Sanford Burnham Prebys Medical Discovery Institute

Project 5: “Transcriptomic and Epigenomic Profiling to Reveal Tumor-Infiltrating Lymphocyte and Microglia Functional Phenotype and Clonality In Pediatric Brain Tumors”
Anusha Preethi Ganesan, Rady Children’s Hospital, San Diego
P. Vijayanand, La Jolla Institute

Project 6: “Responses of Melanoma Patients to Checkpoint Immunotherapy”
Linda Bradley, Sanford Burnham Prebys Medical Discovery Institute
Gregory Daniels, Moores Cancer Center

Project 7: “Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression”
Hannah Carter, Moores Cancer Center
Graham McVicker, Salk Institute for Biological Studies

Project 8: “Epigenetic Profiling of Endometrial Cancer”
戴安娜·哈格里夫斯, Salk Institute for Biological Studies
Ramez Eskander, Moores Cancer Center

Project 9: “Targeting Fibroblast Heterogeneity to Improve Surgical Outcomes in Pancreatic Cancer”
罗纳德·M·埃文斯, Salk Institute for Biological Studies
Michael Bouvet, Moores Cancer Center

Project 10: “A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis”
Peter Zage, Rady Children’s Hospital, San Diego
托尼·亨特, Salk Institute for Biological Studies

Project 11: “Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials”
Paula Aristizabal, Rady Children’s Hospital, San Diego
Elena Martinez, UC San Diego Health

About Padres Pedal the Cause:
Padres Pedal the Cause is a 501(c)(3) nonprofit organization dedicated to funding collaborative cancer research in San Diego. To date, Padres Pedal has raised and donated over $7.1 million to fund 42 translational research projects at Moores Cancer Center at UC San Diego Health, the Salk Institute for Biological Studies, Rady Children’s Hospital and Sanford Burnham Prebys Medical Discovery Institute. It is our goal that the research funded by Padres Pedal the Cause will lead to increased survivorship and ultimately, a cure. For more information or to register for the November 17 event, please visit www.gopedal.org or on Facebook, Instagram and Twitter.

研究领域

更多信息

宣传办公室
电话:(858) 453-4100
press@salk.edu

萨尔克生物学研究所

萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.